Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
Saved in:
| Title: | Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage? |
|---|---|
| Authors: | Arrivé C; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France. carrive1@chu-grenoble.fr.; Univ. Grenoble Alpes, HP2 INSERM U1300, 38041, Grenoble, France. carrive1@chu-grenoble.fr., Hotot M; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France., Jourdil JF; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France., Stanke-Labesque F; Laboratory of Pharmacology, Pharmacogenetics and Toxicology, Grenoble Alpes University Hospital, Grenoble, France.; Univ. Grenoble Alpes, HP2 INSERM U1300, 38041, Grenoble, France. |
| Source: | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 Jul; Vol. 40 (4), pp. 693-712. Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
